2014
DOI: 10.1507/endocrj.ej13-0407
|View full text |Cite
|
Sign up to set email alerts
|

Prednisolone markedly reduced serum IgG4 levels along with the improvement of pituitary mass and anterior pituitary function in a patient with IgG4-related infundibulo-hypophysitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
30
1
2

Year Published

2014
2014
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 43 publications
(35 citation statements)
references
References 31 publications
1
30
1
2
Order By: Relevance
“…With respect to clinical manifestations, both patients presented hypogonadotrophic hypogonadism and one had diabetes insipidus, in agreement with findings in the literature, where 25 of 32 cases presented varying degrees of hypopituitarism, 21 had diabetes insipidus and 16 patients presented both conditions (5) (9).…”
Section: Discussionsupporting
confidence: 89%
See 3 more Smart Citations
“…With respect to clinical manifestations, both patients presented hypogonadotrophic hypogonadism and one had diabetes insipidus, in agreement with findings in the literature, where 25 of 32 cases presented varying degrees of hypopituitarism, 21 had diabetes insipidus and 16 patients presented both conditions (5) (9).…”
Section: Discussionsupporting
confidence: 89%
“…Various disorders such as Riedel's thyroiditis, Mikulicz's disease, retroperitoneal fibrosis, tubulo-interstitial nephritis, and sclerosing cholangitis, among others, are now considered part of this disease spectrum (5).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Glucocorticoids have been found to be beneficial in reducing circulating levels of IgG4 and size of pituitary, and improving pituitary function in a patient with IgG4-related infundibulo-hypophysitis [30]. However, as yet the use of glucocorticoids in the management of IgG4RTD has not been evaluated and established in terms of actual hastening the recovery and reducing the need for long-term levothyroxine supplementation, a sequel of resulting primary hypothyroidism.…”
Section: Treatmentmentioning
confidence: 99%